(AGEN) Agenus - Performance -73.5% in 12m
Compare AGEN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-94.78%
#199 in Group
Rel. Strength
4.45%
#7603 in Universe
Total Return 12m
-73.50%
#152 in Group
Total Return 5y
-94.11%
#135 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: AGEN (-73.5%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: AGEN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AGEN
Total Return (including Dividends) | AGEN | XBI | S&P 500 |
---|---|---|---|
1 Month | 78.82% | 11.81% | 13.81% |
3 Months | -5.88% | -13.61% | -6.30% |
12 Months | -73.50% | -12.29% | 10.65% |
5 Years | -94.11% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | AGEN | XBI | S&P 500 |
1 Month | 85.3% | 72.9% | 83% |
3 Months | -31.7% | -83% | -75.3% |
12 Months | -92.2% | -51.6% | 50.1% |
5 Years | -92.5% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #3 | 59.9% | 57.1% |
3 Month | #80 | 8.95% | 0.44% |
12 Month | #151 | -69.8% | -76.1% |
5 Years | #141 | -92.2% | -97.2% |
FAQs
Does AGEN Agenus outperforms the market?
No,
over the last 12 months AGEN made -73.50%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months AGEN made -5.88%, while XBI made -13.61%.
Over the last 3 months AGEN made -5.88%, while XBI made -13.61%.
Performance Comparison AGEN vs Indeces and Sectors
AGEN vs. Indices AGEN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 5.11% | 65.0% | -17.2% | -84.2% |
US NASDAQ 100 | QQQ | 4.92% | 61.5% | -17.4% | -85.1% |
US Dow Jones Industrial 30 | DIA | 4.70% | 68.8% | -16.9% | -81.2% |
German DAX 40 | DAX | 5.13% | 63.9% | -43.5% | -99.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.93% | 67.0% | -18.0% | -80.9% |
Hongkong Hang Seng | HSI | 1.94% | 58.9% | -25.6% | -87.2% |
India NIFTY 50 | INDA | 10.0% | 74.0% | -17.7% | -73.3% |
Brasil Bovespa | EWZ | 4.06% | 61.6% | -25.9% | -65.2% |
AGEN vs. Sectors AGEN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.47% | 65.4% | -24.3% | -95.1% |
Consumer Discretionary | XLY | 4.73% | 64.6% | -16.2% | -87.8% |
Consumer Staples | XLP | 5.97% | 72.2% | -24.1% | -82.6% |
Energy | XLE | 5.29% | 72.1% | -10.6% | -64.0% |
Financial | XLF | 4.01% | 65.3% | -24.3% | -95.9% |
Health Care | XLV | 8.12% | 78.0% | -12.2% | -69.4% |
Industrial | XLI | 3.42% | 62.0% | -18.6% | -84.5% |
Materials | XLB | 5.31% | 65.3% | -12.3% | -68.3% |
Real Estate | XLRE | 6.43% | 67.3% | -18.0% | -89.0% |
Technology | XLK | 4.03% | 57.6% | -14.3% | -80.6% |
Utilities | XLU | 5.06% | 69.2% | -24.9% | -91.0% |
Aerospace & Defense | XAR | 3.13% | 57.7% | -28.7% | -101% |
Biotech | XBI | 11.7% | 67.0% | 2.93% | -61.2% |
Homebuilder | XHB | 4.64% | 67.3% | -4.02% | -66.0% |
Retail | XRT | 3.21% | 64.2% | -13.0% | -72.0% |